Skip to main content
. 2013 Jun 24;8(6):e66831. doi: 10.1371/journal.pone.0066831

Figure 1. The presence of both KIR2DS3 and IL28B-T alleles synergise to increase the odds of HCV treatment failure.

Figure 1

ORs for KIR2DS3 alone, IL28B-T carriers (CT or TT) alone, and KIR2DS3 with IL28B-T compared with neither risk factor present were calculated from multinominal logisitic regression. The contribution of individual and combined risk factors to the ORs is graphically represented in the bar chart. Positive OR indicates an association with increased odds of treatment failure. aOdds ratio (95% confidence interval). * adjusted OR including HCV genotype and HAART as co-variates.